Effects of chronic treatment with fluoxetine on receptor-stimulated increase of [Ca2+]i in astrocytes mimic those of acute inhibition of TRPC1 channel activity

Primary cultures of mouse astrocytes were used to investigate effects by chronic treatment (3-21 days) with fluoxetine (0.5-10 μM) on capacitative Ca²⁺ influx after treatment with the SERCA inhibitor thapsigargin and on receptor agonist-induced increases in free cytosolic Ca²⁺ concentration [Ca²⁺]_i, determined with Fura-2. The agonists were the 5-HT_2B agonist fluoxetine, the α₂-adrenergic agonist dexmedetomidine, and ryanodine receptor (RyR) and IP₃ receptor (IP₃R) agonists. In untreated sister cultures each agonist distinctly increased [Ca²⁺]_i, but in cultures treated for sufficient length of time or with sufficiently high doses of fluoxetine, acute administration of fluoxetine, dexmedetomidine, or RyR or IP₃R agonists elicited reduced, in some cases abolished, effects. Capacitative Ca²⁺ entry, meditated by TRPC1 channels, was sufficiently inhibited to cause a depletion of Ca²⁺ stores, which could explain the reduced agonist effects. All effects of chronic fluoxetine administration could be replicated by TRPC1 channel antibody or siRNA. Since increases in astrocytic [Ca²⁺]_i regulate release of gliotransmitters, these effects may have profound effects on brain function. They may be important for therapeutic effects of all 5 conventional ‘serotonin-specific reuptake inhibitors’ (SSRIs), which at concentrations used therapeutically (∼1 μM) share other of fluoxetine's chronic effects (Zhang et al., Neuron Glia Biol. 16 (2010) 1-13).     

Chronic fluoxetine administration increases expression of the L-channel gene Cav1.2 in astrocytes from the brain of treated mice and in culture and augments K-induced increase in [Ca]i

We have recently shown that freshly isolated astrocytes from the mouse brain express mRNA for the L-channel gene Ca_v1.3 to at least the same degree (per mg mRNA) as corresponding neurons. The amount of extracellular Ca²⁺ actually entering cultured astrocytes by its opening is modest, but due to secondary Ca²⁺-mediated stimulation of the ryanodine receptor (RyR) the increase in free cytosolic Ca²⁺ [Ca²⁺]_i is substantial. The other Ca_v1 subtype expressed in brain is Ca_v1.2, which is even expressed in higher density. Although the different primers used for the two genes preclude exact quantitative comparison, the present study suggests that this is also the case in the freshly isolated astrocytes and neurons, which express equal Ca_v1.2 densities. Again, most of the increase in [Ca²⁺]_i occurred by RyR activity. In contrast to Ca_v1.3 the expression of Ca_v1.2 was greatly increased (doubled) after two weeks of treatment with fluoxetine hydrochloride (10 mg/kg). Accordingly [Ca²⁺]_i in cultured astrocytes exposed to the addition of 10–60 mM KCl increased substantially in cultured astrocytes treated chronically with fluoxetine with the lag time until the effect was observed depending upon the fluoxetine concentration. This effect was inhibited by nifedipine or siRNA against Ca_v1.2. The increase in K⁺-induced rise in [Ca²⁺]_i after fluoxetine treatment is directly opposite to a decrease in [Ca²⁺]_i after treatment with any of the anti-bipolar drugs lithium, carbamazepine or valproic acid, due to reduced capacitative Ca²⁺ influx. We have previously shown a similar effect after fluoxetine treatment, but it becomes overridden by the Ca_v1.2 up-regulation.